Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature.
Pyomyositis has become an increasingly recognized disease in temperate climates. A patient receiving chlorambucil for progressive systemic sclerosis, in whom streptococcal pyomyositis developed, is presented. Magnetic resonance imaging led to the early diagnosis. To our knowledge, this is the first case report of pyomyositis in a patient with scleroderma, and the first association with group G streptococcus infection in an adult. Connective tissue diseases and immunosuppression may emerge as risk factors for the development of this entity.
Minor
R L
RL
Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City 52242.
Baum
S
S
Schulze-Delrieu
K S
KS
D002699:Chlorambucil / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009220:Myositis / Q000209:etiology*; D012595:Scleroderma, Systemic / Q000150:complications* / Q000188:drug therapy; D013290:Streptococcal Infections / Q000209:etiology*; D013492:Suppuration
D002699:Chlorambucil